Oct 23, 2026
Bristol Myers patient died after CAR-T treatment, company explains June trial pause
Bristol Myers Squibb disclosed that a multiple sclerosis patient died from septic pneumonia following zola-cel CAR-T treatment, linking prior adverse events to manufacturing reagent changes. The company plans to restart trials in early 2025.
5 sources
00